Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments
The purpose of this study is to investigate the perspectives and preferences of patients and healthcare professionals (medical oncologists, pneumologists, thoracic surgeons) regarding treatment options in the resectable non-small cell lung cancer (NSCLC) setting
Non-small Cell Lung Cancer (NSCLC)
DRUG: Approved Non-small Cell Lung Cancer (NSCLC) therapies
Responses to qualitative interview questions, Interview questions designed to gather insights into diagnosis, symptoms, current treatments, perspectives on treatment features and test for mock preferences tasks. The interview will take 15 minutes to complete., Day 1|Patient sociodemographic, Day 1|Patient clinical characteristics, Day 1
The purpose of this study is to investigate the perspectives and preferences of patients and healthcare professionals (medical oncologists, pneumologists, thoracic surgeons) regarding treatment options in the resectable non-small cell lung cancer (NSCLC) setting